Osteopontin directly modulates cytokine expression of primary microglia and increases their survival

J Neuroimmunol. 2016 Oct 15:299:130-138. doi: 10.1016/j.jneuroim.2016.09.009. Epub 2016 Sep 14.

Abstract

Osteopontin (OPN) is constitutively expressed in the brain and upregulated during neuroinflammation, e.g., focal cerebral ischemia. In OPN-deficient mice, microglia are deregulated after ischemia, but specific OPN-effects on microglia remain elusive. Primary microglia were cultured in the presence or absence of OPN. The survival of microglia under stress conditions was dose-dependently increased by OPN. Lipopolysaccharides (LPS)-induced release of nitric oxide (NO), TNF-α, and IL-6, as well as expression of inducible Nitric Oxide Synthase (iNOS), were attenuated by OPN. Data suggest that OPN modulates microglia function by shifting their inflammatory profile towards a neutral anti-inflammatory phenotype.

Keywords: Focal cerebral ischemia; Neural stem cells; Neuroinflammation; Neuroprotection; Regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • Cytokines / biosynthesis*
  • Cytokines / genetics
  • Dose-Response Relationship, Drug
  • Gene Expression
  • Microglia / drug effects*
  • Microglia / metabolism*
  • Osteopontin / pharmacology*
  • Osteopontin / physiology
  • Rats

Substances

  • Cytokines
  • Spp1 protein, rat
  • Osteopontin